[ALNY] QoQ Quarter Result on 30-Sep-2009 [#Q3]

Stock
[ALNY] Alnylam Pharmaceuticals, Inc.
Announcement Date
04-Nov-2009
Financial Year
2009
Quarter
30-Sep-2009 [#Q3]
Profit Trend
QoQ- 59.44%
YoY- -222.18%
Quarter Report
ALNY's Result
ALNY's Financial Summary
View:
Show?
Quarter Result
30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 31/12/08 CAGR
Revenue 26,617 24,564 26,626 24,249 24,601 25,057 24,404 5.97%
PBT -14,861 -12,305 -8,230 -9,760 -21,794 -7,224 -9,336 36.44%
Tax -229 18 -439 -552 908 665 56 -
NP -14,632 -12,323 -7,791 -9,208 -22,702 -7,889 -9,392 34.49%
Tax Rate - - - - - - - -
Total Cost 41,249 36,887 34,417 33,457 47,303 32,946 33,796 14.25%
Ratio Analysis
30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 31/12/08 CAGR
NP Margin -54.97 -50.17 -29.26 -37.97 -92.28 -31.48 -38.49 26.90%
Per Share
30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 31/12/08 CAGR
EPS -0.35 -0.29 -0.19 -0.22 -0.55 -0.19 -0.23 32.40%
EPS Diluted -0.35 -0.29 -0.19 -0.22 -0.55 -0.19 -0.23 32.40%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.